Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease.
D001665:Binding Sites; D005169:Factor VIII; D005260:Female; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D012310:Ristocetin / Q000494:pharmacology*; D014842:von Willebrand Diseases / Q000097:blood / Q000503:physiopathology*
D012310:Ristocetin; D005169:Factor VIII